Home Cart Sign in  
Chemical Structure| 2064269-82-3 Chemical Structure| 2064269-82-3

Structure of YK-029A
CAS No.: 2064269-82-3

Chemical Structure| 2064269-82-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

YK-029A is an orally effective EGFR mutation inhibitor targeting T790M mutations and exon 20 insertions, demonstrating significant antitumor activity in driven PDX models.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of YK-029A

CAS No. :2064269-82-3
Formula : C27H32N8O2
M.W : 500.60
SMILES Code : C=CC(NC1=CC(NC2=NC=CC(C3=CN=C4C(C)=CC=CN43)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
MDL No. :N/A

Safety of YK-029A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of YK-029A

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05767866 Treatment|Treatment Side Effec... More >>ts Less << PHASE1|PHASE2 RECRUITING 2024-05-30 Anhui Provincial Cancer Hospit... More >>al, Hefei, Anhui, 230000, China|Anhui Provincial Hospital, Hefei, Anhui, 230000, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510000, China|People's Hospital of Guangxi Zhuang Autonomous Region, Nanjing, Guangxi, 530000, China|Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, 530000, China|Affiliated Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, 150000, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|The First Affiliated Hospital of Zhengzhou University, Zhenzhou, Henan, 450000, China|Renmin Hospital of Wuhan University, Wuhan, Hubei, 430000, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430000, China|Hunan Cancer Hospital, Changsha, Hunan, 410000, China|Xiangya Hospital Central South University, Changsha, Hunan, 410000, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210000, China|Nanjing Chest Hospital, Nanjing, Jiangsu, 210000, China|Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjin, Jiangsu, 210000, China|Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China|Xuzhou Central Hospital, Xuzhou, Jiangsu, 221000, China|Jilin Tumor Hospital, Chang chun, Jilin, 130000, China|First Hospital of Jilin University, Changchun, Jilin, 130000, China|Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, 110000, China|Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, 110000, China|The First Affiliated Hospital of China Medical University, ShenYang, Liaoning, 110000, China|Shanxi Cancer Hospital, Taiyuan, Shanxi, 030000, China|the First Affiliated Hospital; Medical College of Xi'an Jiaotong University, Xi'an, Shanxi, 710000, China|Tianjin Cancer Hospital, Tianjin, Tianjin, 300000, China|Cancer in Zhejiang Province, Hangzhou, Zhejiang, 310000, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China|Peking Union Medical College Hospital, Beijing, 10000, China|Beijing Chest Hospital Affiliated to Capital Medical University, Beijing, 100102, China|Beijing Hospital, Beijing, 100102, China|Beijing Tiantan Hospital affiliated to Capital Medical University, Beijing, 100102, China|National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100102, China|Peking University Cancer Hospital, Beijing, 100102, China|The Fifth Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, 100102, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

9.99mL

2.00mL

1.00mL

19.98mL

4.00mL

2.00mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories